Jan 6, 2026 · AstraZeneca’s investigational ATR kinase inhibitor did not improve overall survival when combined with Imfinzi in patients with non-small cell lung cancer during a Phase III …

Aug 1, 2022 · Anonymous board for AstraZeneca. We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in …

Nov 26, 2025 · The FDA has recently approved AstraZeneca’s Imfinzi (durvalumab) for perioperative use in cisplatin-eligible muscle-invasive bladder cancer (MIBC), based on the …

Dec 4, 2025 · Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, …

Jan 6, 2026 · AstraZeneca’s fully human monoclonal antibody, Saphnelo (anifrolumab) subcutaneous (SC) administration has shown a decrease in disease activity in individuals with …

Aug 23, 2023 · Caprelsa AstraZeneca sells rare cancer drug to Sanofi for up to $300 million Submitted by admin on Mon, 07/27/2015 - 10:00 Read more about AstraZeneca sells rare …

Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales

Nov 21, 2025 · AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times reported on Tuesday, citing multiple sources.

Dec 4, 2025 · In return for the exclusive rights, AstraZeneca’s Alexion Pharmaceuticals rare disease unit is liable to pay up to $780 million in a combination of upfront and potential …

Nov 18, 2022 · Arcutis Biotherapeutics is on a roll. Months after launching its topical formulation of an old AstraZeneca drug in plaque psoriasis, the company is touting positive Phase III data in …